In this study, we mainly determined whether gankyrin facilitates the progression and targeted drug resistance of ccRCC, and examined whether the integration of gankyrin and STAT3 or CCL24 expression with established clinical indicators results in improved prediction of the prognosis of ccRCC patients. The gene discussed is CCL24; the disease is nonpapillary renal cell carcinoma.